Phone: 301-655-1084 Email: info@glycorx.com

GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)

June 3, 2020
Hafiz Ahmed
Headlines
0 Comments

GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)

June 03, 2020

GlycoMantra was awarded a SBIR Phase 1 grant to investigate insulin resistance in type 2 diabetes.

Hafiz Ahmed

previous post: GlycoMantra will present at the Oncology Investor Conference.
next post: SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted type 2 diabetes